Bharat Biotech announces COVAXIN capacity expansion EP News Bureau Apr 20, 2021 Bharat Biotech has partnered with Indian Immunologicals (IIL) to manufacture the drug substance for COVAXIN
Lilly and Amgen to collaborate for manufacturing COVID-19 antibody therapies EP News Bureau Sep 18, 2020 Together, the companies hope to be able to produce many millions of doses even next year